Korro Bio Ops, Inc
Advertisement
Korro Bio Ops, Inc, based in Cambridge, MA, is dedicated to advancing the field of genetic medicine by employing innovative RNA editing techniques to address complex and prevalent diseases. Their proprietary platform, Oligonucleotide Promoted Editing of RNA (OPERA), enables precise genetic modifications aimed at repairing proteins affected by genetic mutations.
The company's research focuses on conditions such as Alpha-1 Antitrypsin Deficiency (AATD), an inherited genetic disorder caused by a single-letter change in the SERPINA1 gene. Korro Bio is committed to delivering clinical benefits through their versatile pipeline of drug candidates designed to target and modulate biological pathways for a range of diseases.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement